Jacobs Levy Equity Management, Inc Corcept Therapeutics Inc Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 455,451 shares of CORT stock, worth $33.5 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
455,451
Previous 1,349,682
66.25%
Holding current value
$33.5 Million
Previous $154 Million
78.31%
% of portfolio
0.14%
Previous 0.65%
Shares
13 transactions
Others Institutions Holding CORT
# of Institutions
461Shares Held
82.2MCall Options Held
479KPut Options Held
996K-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$712 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$568 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$461 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$285 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.88B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...